<DOC>
	<DOCNO>NCT01736696</DOCNO>
	<brief_summary>This study conduct subject psoriasis evaluate drug activity patient population analysis change psoriatic lesion biopsy characteristic . This subject population select evaluate potentially relevant biological activity CP-690,550 well assess safety pharmacokinetics .</brief_summary>
	<brief_title>Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Male and/or female subject age 18 65 year , inclusive , active psoriasis lesion ( ) . Subjects healthy exception psoriasis , healthy define clinically relevant abnormality identify detailed medical history , full physical examination . Blood pressure must &lt; 140/89 . Body Mass Index ( BMI ) 1836 kg/m2 , inclusive ; total body weight &gt; 50 kg ( 110 lb ) The following laboratory variable must 10 % low limit normal reference range : RBC , hemoglobin , hematocrit , WBC , absolute neutrophil count . The absolute lymphocyte count must great equal low limit reference range . Values AST , ALT , bilirubin alkaline phosphatase must 10 % upper limit normal reference range . Values total cholesterol LDL must 20 % upper limit normal reference range except subject treat hyperlipidemia . Normal glomerular filtration rate ( &gt; 80 mL/min ) . Subjects evidence history clinically significant hematological , renal , urological , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic disorder . Subjects control essential hypertension and/or hyperlipidemia may eligible study provide medication administer . Screening 12lead ECG demonstrate least one following : heart rate &gt; 100 bpm , QRS &gt; 120 msec , QTc &gt; 430 msec ( male ) , QTc &gt; 450 msec ( female ) PR &gt; 220 msec . Abnormal chest radiograph include , limited , evidence past present tuberculosis infection . History tuberculosis without treatment and/or positive tuberculin reaction without know vaccination BCG . Subjects history tumor exception adequately treat basal cell carcinoma skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>PASI</keyword>
	<keyword>plaque</keyword>
	<keyword>skin biopsy</keyword>
	<keyword>immunomodulation</keyword>
</DOC>